Maturation of type I and type II rat vestibular hair cells in vivo and in vitro DOI Creative Commons
Mireia Borrajo, David Sedano, Aïda Palou

и другие.

Frontiers in Cell and Developmental Biology, Год журнала: 2024, Номер 12

Опубликована: Июнь 4, 2024

Vestibular sensory epithelia contain type I and II hair cells (HCI HCII). Recent studies have revealed molecular markers for the identification of these cells, but precise composition each vestibular epithelium (saccule, utricle, lateral crista, anterior posterior crista) their postnatal maturation not been described in detail. Moreover, vitro methods to study this are well developed. We obtained total HCI HCII counts adult rats studied from birth (P0) day 28 (P28). Adult were found comprise ∼65% expressing osteopontin PMCA2, ∼30% calretinin, ∼4% SOX2 neither nor calretinin. At birth, immature HCs express both P28 showed an almost adult-like still contained 1.3% HCs. In addition, we free-floating 3D cultures at P1, which formed a fluid-filled cyst, survival up (28 DIV). These good HC resiliency maturation. Using enriched medium initial 4 days, HCI/calretinin+-HCII ratio close vivo was obtained. suitable mature pharmacological, toxicological research.

Язык: Английский

Inner Ear Organoids: Strengths and Limitations DOI Creative Commons
Giulia Pianigiani, Marta Roccio

Journal of the Association for Research in Otolaryngology, Год журнала: 2024, Номер 25(1), С. 5 - 11

Опубликована: Фев. 9, 2024

Abstract Inner ear organoids derived from differentiation of human pluripotent stem cells have recently gained momentum as tools to study inner development and developmental defects. An additional exciting aspect about this technology is represented by its translational potential, specifically, the use validate therapeutics for hearing balance restoration on human/patient-specific cells. This latter will be briefly discussed here including opportunities current limitations.

Язык: Английский

Процитировано

4

Cochlear Implantation Outcomes in Genotyped Subjects with Sensorineural Hearing Loss DOI Creative Commons
M. L. A. Fehrmann, Lonneke Haer‐Wigman, Hannie Kremer

и другие.

Journal of the Association for Research in Otolaryngology, Год журнала: 2025, Номер unknown

Опубликована: Апрель 23, 2025

Abstract Purpose Cochlear implants (CIs) are an effective rehabilitation option for individuals with severe-to-profound sensorineural hearing loss (SNHL). While genetic factors play a significant role in SNHL, the variability CI outcomes remains unclear. This study evaluated short- and long-term large genotyped cohort investigated correlations defects their cochlear site-of-lesion. Methods retrospective, single-center, included 220 subjects (127 females; 299 ears) pathogenic variants identified 31 different nuclear genes mitochondrial genes. Audiological were measured pre- post-implantation. site-of-lesion was categorized as pre-synaptic, post-synaptic, or mitochondrial, based on gene function expression. Multiple regression analysis assessed influencing outcomes, including age at implantation, SNHL duration, aid (HA) use, Results showed median phoneme score of 90%, better early implantation (≤ 6 years). Variability not linked to site-of-lesion, but subject-specific factors, such duration pre-implantation HA experience. A model incorporating these explained 19% total variance outcomes. Poorer (phoneme scores < 70%) more common prolonged auditory deprivation older implantation. Conclusion Genotyped recipients demonstrated excellent largely attributed non-genetic factors. These findings show that is beneficial type most hereditary underscore importance

Язык: Английский

Процитировано

0

Emerging Trends in Biosensor and Microfluidics Integration for Inner Ear Theragnostics DOI Creative Commons
Behrouz Aghajanloo, Simin Nazarnezhad,

Faezeh Arshadi

и другие.

Biosensors and Bioelectronics, Год журнала: 2025, Номер 286, С. 117588 - 117588

Опубликована: Май 15, 2025

Advancements in inner ear theragnostics are critical for addressing the pervasive challenges of diagnosing and treating hearing balance disorders, which significantly impact quality life. This paper reviews biosensors devices that leverage advanced functional nanomaterials, microfabrication techniques, nano-biotechnology to enhance theragnostic applications ear. The highlights development diverse electromechanical, electrochemical, biomarker sensors theragnostics. Electromechanical replicate cochlear vestibular sensory structures through bioinspired designs, while electrochemical used measure level ions chemicals fluid, providing insights into health disease organs. Biomarker focus on screening diseases early detection correlated biomarkers based point care diagnostics. study also examines use microfluidic with elements provide a compact integrated model fluid-filled cochlea. In addition, delivery strategies, including targeted drug systems nanocarriers explored their ability improve penetration distribution therapeutics within importance pharmacokinetics post-treatment monitoring as indicators assessing efficacy micro/nanotechnology-based approaches. By consolidating these innovations, this work offers comprehensive framework advancing otology, paving way novel diagnostic tools, effective treatments, future clinical applications.

Язык: Английский

Процитировано

0

Maturation of type I and type II rat vestibular hair cells in vivo and in vitro DOI Creative Commons
Mireia Borrajo, David Sedano, Aïda Palou

и другие.

Frontiers in Cell and Developmental Biology, Год журнала: 2024, Номер 12

Опубликована: Июнь 4, 2024

Vestibular sensory epithelia contain type I and II hair cells (HCI HCII). Recent studies have revealed molecular markers for the identification of these cells, but precise composition each vestibular epithelium (saccule, utricle, lateral crista, anterior posterior crista) their postnatal maturation not been described in detail. Moreover, vitro methods to study this are well developed. We obtained total HCI HCII counts adult rats studied from birth (P0) day 28 (P28). Adult were found comprise ∼65% expressing osteopontin PMCA2, ∼30% calretinin, ∼4% SOX2 neither nor calretinin. At birth, immature HCs express both P28 showed an almost adult-like still contained 1.3% HCs. In addition, we free-floating 3D cultures at P1, which formed a fluid-filled cyst, survival up (28 DIV). These good HC resiliency maturation. Using enriched medium initial 4 days, HCI/calretinin+-HCII ratio close vivo was obtained. suitable mature pharmacological, toxicological research.

Язык: Английский

Процитировано

0